Newly Diagnosed Multiple Myeloma Not Yet Recruiting Phase Trials for Daratumumab (DB09331)

Also known as: Newly Diagnosed Multiple Myeloma (NDMM) / Newly Diagnosed, Multiple Myeloma / Multiple Myeloma, Newly Diagnosed

IndicationStatusPhase
DBCOND0036257 (Newly Diagnosed Multiple Myeloma)Not Yet RecruitingNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT05561049Efficacy and Safety of Daratumumab in Combination With Bortezomib, Thalidomide, and Dexamethasone Regimens in Newly Diagnosed Multiple Myeloma
NCT05088330A Study to Access of Daratumumab Combined With VRD in the Treatment of Patients With Standard-risk Newly Diagnosed MMTreatment